chr7-92566027-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152789.4(FAM133B):c.644G>A(p.Arg215Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152789.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM133B | NM_152789.4 | c.644G>A | p.Arg215Gln | missense_variant | Exon 10 of 11 | ENST00000445716.6 | NP_690002.2 | |
FAM133B | NM_001040057.3 | c.614G>A | p.Arg205Gln | missense_variant | Exon 11 of 12 | NP_001035146.1 | ||
FAM133B | NM_001288584.2 | c.614G>A | p.Arg205Gln | missense_variant | Exon 10 of 11 | NP_001275513.1 | ||
FAM133B | NR_109929.2 | n.702G>A | non_coding_transcript_exon_variant | Exon 10 of 11 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248908Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135074
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461494Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 727012
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.644G>A (p.R215Q) alteration is located in exon 10 (coding exon 10) of the FAM133B gene. This alteration results from a G to A substitution at nucleotide position 644, causing the arginine (R) at amino acid position 215 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at